Ruth Plummer

Ruth Plummer

Professor Ruth Plummer

Nationality	British
Known for	Development of PARP inhibitors

Ruth Plummer is a renowned British oncologist and professor known for her pioneering work in the development of PARP inhibitors, a class of drugs used in the treatment of cancer. She is a leading figure in the field of oncology and has contributed significantly to clinical trials and cancer research.

Early Life and Education

Ruth Plummer was born in the United Kingdom. She pursued her medical education at a prestigious university, where she developed an interest in oncology. Her early academic career was marked by a focus on cancer biology and the mechanisms of cancer cell survival.

Career

Ruth Plummer is a professor of experimental cancer medicine at Newcastle University. She is also a consultant medical oncologist at the Northern Centre for Cancer Care. Her work primarily focuses on the development of new cancer therapies, particularly those targeting DNA repair mechanisms in cancer cells.

Research Contributions

Plummer's most notable contribution to cancer research is her work on PARP inhibitors. These inhibitors are a breakthrough in cancer treatment, particularly for breast cancer and ovarian cancer patients with BRCA1 or BRCA2 mutations. Her research has been instrumental in the clinical development and approval of these drugs, which have improved survival rates for many cancer patients.

Clinical Trials

Ruth Plummer has been involved in numerous clinical trials, testing the efficacy and safety of new cancer treatments. Her work in this area has helped bring several new therapies from the laboratory to the clinic, providing new hope for patients with difficult-to-treat cancers.

Awards and Honors

Throughout her career, Ruth Plummer has received numerous awards and honors for her contributions to cancer research and treatment. She is recognized as a leader in her field and has been invited to speak at international conferences and symposia.

Publications

Ruth Plummer has authored and co-authored numerous scientific papers and articles in leading medical journals. Her publications cover a wide range of topics in oncology, including the development of targeted therapies and the role of DNA repair in cancer.

Also see

• Oncology
• PARP inhibitors
• BRCA1
• BRCA2
• Breast cancer
• Ovarian cancer